Skip to content

Author

Danh Q. Nguyen

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Sep 2026

Oral PCSK9 inhibitors: closing the gap between potency and practicality.

PURPOSE OF REVIEW Oral proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors represent a new generation of lipid-lowering therapies that combine the potency of injectable PCSK9 inhibitors with the convenience of oral administration. This review examines the mechanisms, trial evidence, and implementation cons...

Danh Q. Nguyen, N. Pagidipati, A. Navar · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.